The last time we wrote about baby biotech Galapagos NV (PINK ADR: GLPYY), the Private Briefing column featured the headline: "On This Stock, the Good News Just Keeps Coming." Today's follow-up column could feature the very same headline. That's because knowledgeable outsiders (including Johnson & Johnson Inc. (NYSE: JNJ), this time around) keep buying big […]
This is premium content for Private Briefing subscribers only.
Since 2011, Executive Editor Bill Patalon has been quietly making tens of thousands of Americans incredibly wealthy through an unconventional strategy that has produced over 74 winning investment plays. To learn why Bill has been called one of the most exciting new talents in the industry... and to get access to the 7 Best stocks to own this year, click the button below.